Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MBrace Therapeutics

Request full access

REACHING TO IMPROVE THE LIVES OF

San Diego, United StatesFounded 2020Biotech & Life Sciences

About MBrace Therapeutics

MBrace is a healthcare startup that focuses on developing innovative treatments for cancer patients. The company's primary technology, known as SPARTA, is a robust antibody discovery methodology that helps to overcome challenges in generating human antibodies for clinical applications. This technology is used to develop Antibody-Drug Conjugates (ADCs), a type of targeted therapy that delivers cancer-killing drugs directly to cancer cells, against two novel cancer targets.

MBrace's business model revolves around the research, development, and commercialization of these new treatments. The company's primary clients are cancer patients who are in need of more effective and targeted treatment options. The company operates in the biotechnology and healthcare market, a sector that is continually growing due to the increasing prevalence of various types of cancer and the ongoing need for more effective treatments.

The company also collects and uses data from various sources, including information provided by individuals for job applications or inquiries. This data is used for a variety of purposes, including analytics and improving the company's services. MBrace also discloses deidentified and aggregated information about its users without restriction, which could potentially provide additional revenue streams.

In summary, MBrace is a biotech startup that uses its proprietary SPARTA technology to develop targeted cancer treatments. The company operates in the healthcare market, serving cancer patients and using collected data to improve its services and potentially generate additional revenue.

Source: Dealroom company data

At a glance

Status
Operational
Employees
26
Open positions
None listed
Dealroom signal
45.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2023 $85M $340M TPG · Venrock · Alta Partners · Avidity Partners ↗
SERIES AOther financing Jan 2021 $25M $100M Venrock · Alta Partners ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

MBrace Therapeutics website traffic

Latest recorded traffic for MBrace Therapeutics is 3.9K monthly website visits, down 11.4% over the last three months. MBrace Therapeutics's team grew 8.3% over the past year.

Latest monthly visits3.9K 3-month web change-11.4% 1-year team growth+8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

MBrace Therapeutics in the San Diego ecosystem

Live from Dealroom

The MBrace Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Venrock
  • Alta Partners
  • TPG
  • Avidity Partners
  • Cowen Healthcare Investments

Other known investors1 additional known investor

  • Rutgers university
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MBrace Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MBrace Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.